The True Potential of Hemp: What the Future Holds
From the very start of cannabis stigmatisation and prohibition, hemp was unfairly lumped into the same category as 'marijuana,' 'weed,' or even the evocative 'ganja,’
Use our chat feature to speak with one of our expert consultants who can help you identify if medical cannabis can help you.
Get the latest Releaf Cannabis Clinic news, updates, and announcements. Stay informed about our services, events, and medical cannabis expertise.
From the very start of cannabis stigmatisation and prohibition, hemp was unfairly lumped into the same category as 'marijuana,' 'weed,' or even the evocative 'ganja,’
Every year on the 23rd of January, National Reading Day is recognised - a campaign to encourage a lifelong habit of reading from childhood to adulthood.
In December 2024, Releaf’s website attracted 9510 daily visits and nearly 1,000 page views an hour. In this blog we break down the data, and evaluate why thousands trust our reliable content about medical cannabis in the UK.
As the first medical cannabis clinic in the UK to provide their patients with medical cannabis cards, at Releaf we’re often asked ‘what's the difference between Releaf’s medical cannabis cards and Cancard?’ - and, we’re here to clear up the confusion.
Just started medical cannabis treatment with Releaf? A little confused about what is the most effective way to take your Releaf medical cannabis flower or oil?
Almost a year after launching, the Cannabis Industry Council’s ‘Yes We Can’ research report was published, revealing what UK based medical cannabis patients think about various aspects of the medical cannabis industry. Here, we take a look at what they found, and, what this could mean.
Here at Releaf, we understand that getting your medication quickly, safely, discreetly, and tracked from dispatch to delivery is one of the most important aspects of every patient's medical cannabis treatment journey.
January is Glaucoma Awareness Month - a time to raise awareness and support for those living with glaucoma, the world’s leading cause of blindness.
At Releaf, one of our core commitments is to provide accurate, reliable and relevant information about medical cannabis treatments here in the UK, and in order to do this we’ve conducted our own research on numerous occasions.
At Releaf, our mission is to enhance the quality of life of individuals across the UK by giving them back control of their health. And throughout 2024, as well as providing patient-focused care and unwavering support through our expert clinical and patient support teams, we’ve had the privilege of speaking with our patients one on one to find out more about their health journeys.
Along with adapting to a whole new treatment option, patients just starting with medical cannabis treatment can sometimes find themselves feeling a little inundated by the terminology, acronyms, and jargon that accompany their treatment plan. One of the key terms for new patients to get their head around is MDT: Multidisciplinary Team.
We all suffer from bloating, cramping, and constipation from time to time, but certain conditions and medications can make these symptoms particularly problematic.
Explore the potential of medical cannabis in 2025 as an alternative healthcare option in the UK. Learn how Releaf helps patients address health concerns like anxiety, chronic pain, and more with personalised, patient-centred treatment plans. Discover the benefits, conditions eligible for treatment, and how to take the first step toward a healthier you this New Year.
While most people look for alternative treatment options because conventional medicines haven’t met their needs, an increase in prescription drug shortages in the UK is leaving more patients without access to effective medications.
With UK medical cannabis going nothing short of viral in the past 12 months or so (and patient numbers climbing at an exponential rate), the need for clear, concise information regarding medical cannabis accessories has never been more obvious.
This year, we’ve taken a leaf from Spotify’s book and put together a collection of our favourite moments during 2024. As the year draws to a close, here we reflect on our milestones, growth, and most importantly, the transformative difference we’re making for patients.
Releaf has been at the forefront of the UK medical cannabis sector throughout 2024, garnering widespread media attention for its innovative patient-first approach and groundbreaking initiatives. From leading the conversation around accessibility to driving awareness of medical cannabis treatment options, Releaf has consistently made headlines, shaping the narrative of this rapidly evolving industry. With notable features in national publications and influential platforms, the spotlight on Releaf reflects its commitment to transforming lives and redefining the future of medical cannabis care in the UK.
With the holiday season less than two weeks away, we want to make sure each and every Releaf patient is well-prepared for the slight changes to our normal operating schedule - and the minor adjustments to medication delivery during this year's festive period.
The holiday season is fast approaching, and with it, the yearly yearning to pack your bags, hit the road and hopefully escape the winter blues.
The days are drawing in and Christmas is right around the corner. Many of us will be working our way down Christmas lists, trying to find the perfect presents for our loved ones.
The winter months can be tough for all of us, but especially those living with chronic health conditions who may see their symptoms worsen with the lower temperatures.
More people throughout the UK are looking for alternative options to manage long-term health conditions.
Medical cannabis has demonstrated therapeutic potential across a wide range of conditions and symptoms, including muscle spasms.
Last year, our representative research found 68% of UK adults would consider medical cannabis treatment if their doctor recommended it, but around 1 in 4 said they would be apprehensive about, and perhaps discouraged by, the costs involved.